Sinocare's blood glucose monitoring gross margin 2018-2022
In 2021, the gross margin of Sinocare's blood glucose monitoring sales in China was approximately 66 percent, decreasing from around 70 percent in the previous year. Overall, the gross margin remained above 65 percent.